HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN IS MODIFIED BY O-LINKED OLIGOSACCHARIDES

被引:68
作者
BERNSTEIN, HB
TUCKER, SP
HUNTER, E
SCHUTZBACH, JS
COMPANS, RW
机构
[1] EMORY UNIV, SCH MED, DEPT MICROBIOL & IMMUNOL, ROLLINS RES CTR 3001, ATLANTA, GA 30322 USA
[2] UNIV ALABAMA, DEPT MICROBIOL, BIRMINGHAM, AL 35294 USA
[3] SEARLE RES & DEV, INFECT DIS SECT, ST LOUIS, MO 63198 USA
关键词
D O I
10.1128/JVI.68.1.463-468.1994
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein has been shown to be extensively modified by N-linked glycosylation; however, the presence of O-linked carbohydrates on the glycoprotein has not been firmly established. We have found that enzymatic deglycosylation of the HIV-1 envelope glycoprotein with neuraminidase and O-glycosidase results in a decrease in the apparent molecular weight of the envelope glycoprotein. This result was observed in both vaccinia virus recombinant-derived envelope glycoproteins and glycoproteins derived from the IIIB, SG3, and HIV2, strains of HIV-1. The decrease in molecular weight was also observed when the envelope glycoprotein had been deglycosylated with N-glycanase F after treatment with neuraminidase and O-glycosidase, indicating that the decrease in apparent molecular weight was not attributable to the removal of N-linked carbohydrate. Treatment with neuraminidase, O-glycosidase, and N-glycanase F was found to be necessary to remove all radiolabel from [H-3] glucosamine-labelled envelope glycoprotein, a result seen for both recombinant and HIV-1-derived envelope glycoprotein. [H-3]glucosamine-labelled carbohydrates liberated by O-glycosidase treatment were separated by paper chromatography and were found to be of a size consistent with O-linked oligosaccharides. We, therefore, conclude that the HIV-1 envelope glycoprotein is modified by the addition of O-linked carbohydrates.
引用
收藏
页码:463 / 468
页数:6
相关论文
共 40 条
[1]   MAJOR GLYCOPROTEIN ANTIGENS THAT INDUCE ANTIBODIES IN AIDS PATIENTS ARE ENCODED BY HTLV-III [J].
ALLAN, JS ;
COLIGAN, JE ;
BARIN, F ;
MCLANE, MF ;
SODROSKI, JG ;
ROSEN, CA ;
HASELTINE, WA ;
LEE, TH ;
ESSEX, M .
SCIENCE, 1985, 228 (4703) :1091-1094
[2]   SULFATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS ENVELOPE GLYCOPROTEIN [J].
BERNSTEIN, HB ;
COMPANS, RW .
JOURNAL OF VIROLOGY, 1992, 66 (12) :6953-6959
[3]  
CUMMINGS RD, 1989, METHOD CELL BIOL, V32, P141
[4]   BIOSYNTHESIS AND PROCESSING OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 ENVELOPE GLYCOPROTEINS - EFFECTS OF MONENSIN ON GLYCOSYLATION AND TRANSPORT [J].
DEWAR, RL ;
VASUDEVACHARI, MB ;
NATARAJAN, V ;
SALZMAN, NP .
JOURNAL OF VIROLOGY, 1989, 63 (06) :2452-2456
[5]   FOLDING, INTERACTION WITH GRP78-BIP, ASSEMBLY, AND TRANSPORT OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE PROTEIN [J].
EARL, PL ;
MOSS, B ;
DOMS, RW .
JOURNAL OF VIROLOGY, 1991, 65 (04) :2047-2055
[6]   GLYCOSYLATION AND OLIGOMERIZATION OF THE SPIKE PROTEIN OF MARBURG VIRUS [J].
FELDMANN, H ;
WILL, C ;
SCHIKORE, M ;
SLENCZKA, W ;
KLENK, HD .
VIROLOGY, 1991, 182 (01) :353-356
[7]   DETECTION OF A FUSION PEPTIDE SEQUENCE IN THE TRANSMEMBRANE PROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS [J].
GALLAHER, WR .
CELL, 1987, 50 (03) :327-328
[8]  
GARTNER S, 1990, TECHNIQUES HIV RES, P53
[9]  
GEYER H, 1988, J BIOL CHEM, V263, P11760
[10]   OLIGOSACCHARIDES AT INDIVIDUAL GLYCOSYLATION SITES IN GLYCOPROTEIN-71 OF FRIEND MURINE LEUKEMIA-VIRUS [J].
GEYER, R ;
DABROWSKI, J ;
DABROWSKI, U ;
LINDER, D ;
SCHLUTER, M ;
SCHOTT, HH ;
STIRM, S .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1990, 187 (01) :95-110